Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM study
<p>Abstract</p> <p>Background</p> <p>To determine if novel measures of cardiovascular health are associated with prevalence or progression of age-related macular degeneration (AMD).</p> <p>Methods</p> <p>Measures of the cardiovascular system: inc...
Main Authors: | Dimitrov Peter, Robman Luba D, McGrath Barry, Cameron James, Dowrick Adam, McCarty Catherine A, Tikellis Gabriella, Nicolas Caroline, McNeil John, Guymer Robyn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | BMC Ophthalmology |
Online Access: | http://www.biomedcentral.com/1471-2415/8/25 |
Similar Items
-
Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.
by: Robyn H Guymer, et al.
Published: (2013-01-01) -
Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
by: Eleonora M. Lad, et al.
Published: (2023-09-01) -
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
by: Matthews Jane P, et al.
Published: (2008-06-01) -
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration
by: Matthews Jane P, et al.
Published: (2008-09-01) -
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Liubov Robman, et al.
Published: (2017-06-01)